Tara Gomes

PhD, MHSc

Scientist, Li Ka Shing Knowledge Institute

Biography

Please note Dr. Gomes will not be accepting summer students in 2019.

Dr. Tara Gomes is an epidemiologist and Principal Investigator of the Ontario Drug Policy Research Network (ODPRN), a provincial network of researchers with expertise in pharmaceutical utilization, outcomes and policy who rapidly conduct research for drug decision-makers in Ontario and across Canada.  She is also a Scientist in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences and an assistant professor at the University of Toronto.  Her research is focused on pharmacoepidemiology, drug safety and drug policy research leveraging large, administrative databases, and she has published over 125 peer-reviewed articles and over 50 policy reports in this area.

Dr. Gomes has worked closely with the Ontario Ministry of Health and Long-Term Care and the Canadian Network for Observational Drug Effect Studies (CNODES) to develop evidence to inform policies related to opioid use and abuse in Ontario and more broadly across Canada.  She has also served as an expert for the US Food and Drug Administration and the US Department of Transportation in discussions related to opioid policies and regulations. In 2014, the ODPRN was awarded the Institute for Public Administration of Canada’s Bronze Public Sector Leadership Award in Health and Education.

Recent Publications

  1. Tadrous, M, Knowles, S, Ruddock, B, Oh, P, Mamdani, MM, Juurlink, DN et al.. Comprehensive Drug-Class Review Framework for improved evidence-based drug policy and formulary modernization. Int J Technol Assess Health Care. 2019; :1-8. doi: 10.1017/S0266462319000746. PubMed PMID:31796132 .
  2. Wang, HT, Hill, AD, Gomes, T, Pinto, R, Wijeysundera, DN, Scales, DC et al.. Trends in opioid use before critical illness among elderly patients in Ontario. J Crit Care. 2019;55 :128-133. doi: 10.1016/j.jcrc.2019.10.004. PubMed PMID:31715530 .
  3. Muratov, S, Lee, J, Holbrook, A, Guertin, JR, Mbuagbaw, L, Paterson, JM et al.. Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study. BMJ Open. 2019;9 (10):e028637. doi: 10.1136/bmjopen-2018-028637. PubMed PMID:31662356 PubMed Central PMC6830474.
  4. Choremis, B, Campbell, T, Tadrous, M, Martins, D, Antoniou, T, Gomes, T et al.. The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study. PLoS ONE. 2019;14 (10):e0223589. doi: 10.1371/journal.pone.0223589. PubMed PMID:31626648 PubMed Central PMC6799925.
  5. Mamdani, M, Gomes, T, Greaves, S, Manji, S, Juurlink, DN, Tadrous, M et al.. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide. JAMA Netw Open. 2019;2 (10):e1913304. doi: 10.1001/jamanetworkopen.2019.13304. PubMed PMID:31617924 PubMed Central PMC6806420.
  6. Persaud, N, Bedard, M, Boozary, AS, Glazier, RH, Gomes, T, Hwang, SW et al.. Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial. JAMA Intern Med. 2019; :. doi: 10.1001/jamainternmed.2019.4472. PubMed PMID:31589276 PubMed Central PMC6784757.
  7. Leece, P, Chen, C, Manson, H, Orkin, AM, Schwartz, B, Juurlink, DN et al.. One-Year Mortality After Emergency Department Visit for Nonfatal Opioid Poisoning: A Population-Based Analysis. Ann Emerg Med. 2019; :. doi: 10.1016/j.annemergmed.2019.07.021. PubMed PMID:31561997 .
  8. Iaboni, A, Campitelli, MA, Bronskill, SE, Diong, C, Kumar, M, Maclagan, LC et al.. Time trends in opioid prescribing among Ontario long-term care residents: a repeated cross-sectional study. CMAJ Open. ;7 (3):E582-E589. doi: 10.9778/cmajo.20190052. PubMed PMID:31551235 PubMed Central PMC6759016.
  9. Muratov, S, Lee, J, Holbrook, A, Paterson, JM, Guertin, JR, Mbuagbaw, L et al.. Unplanned index hospital admissions among new older high-cost health care users in Ontario: a population-based matched cohort study. CMAJ Open. ;7 (3):E537-E545. doi: 10.9778/cmajo.20180185. PubMed PMID:31451447 PubMed Central PMC6710084.
  10. Xu, Y, Schulman, S, Dowlatshahi, D, Holbrook, AM, Simpson, CS, Shepherd, LE et al.. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding. Thromb. Res. 2019;182 :12-19. doi: 10.1016/j.thromres.2019.07.026. PubMed PMID:31434018 .
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Scientist, Institute for Clinical Evaluative Sciences
  • Principal Investigator, Ontario Drug Policy Research Network
X